English
Home > Products > 272778-12-8

China 272778-12-8 Factory

We take "customer-friendly, quality-oriented, integrative, innovative" as objectives. "Truth and honesty" is our administration ideal for 272778-12-8,CAS NO 272778-12-8,Ezetimibe intermediate,Ezetimibe advance intermediate,3-[(2R,5S)-5-(4-Fluorophenyl)-2, We believe we'll become a leader in building and producing top quality merchandise in the two Chinese and international markets. We hope to cooperate with much more close friends for mutual gains.
272778-12-8, We always insist on the principle of "Quality and service are the life of the product". Till now, our products have been exported to more than 20 countries under our strict quality control and high level service.

Related Products

Hot Products

  • trans-4-Cyclohexyl-L-proline hydrochloride

    trans-4-Cyclohexyl-L-proline hydrochloride

    Product Name:trans-4-Cyclohexyl-L-proline hydrochloride
    Molecular Formula:C11H20ClNO2
    Molecular Weight:233.74
    CAS Registry Number:90657-55-9
  • 2',2'-Difluoro-2'-deoxycytidine-3',5'-dibenzoate

    2',2'-Difluoro-2'-deoxycytidine-3',5'-dibenzoate

    Product Name:2',2'-Difluoro-2'-deoxycytidine-3',5'-dibenzoate
    Molecular Formula:C23H19F2N3O6
    Molecular Weight:471.41
    CAS Registry Number:134790-39-9
  • Vilazodone

    Vilazodone

    Product Name:Vilazodone
    Molecular Formula:C26H27N5O2
    Molecular Weight;441.52
    CAS Registry Number;163521-12-8
  • Blueberry extract

    Blueberry extract

    Product Name:Blueberry extract
    Molecular Formula:C27H31O16
    Molecular Weight;611.53
    CAS Registry Number;84082-34-8
  • 4-Chloro-3-nitrobenzenesulfonyl chloride

    4-Chloro-3-nitrobenzenesulfonyl chloride

    Product Name:4-Chloro-3-nitrobenzenesulfonyl chloride
    Molecular Formula:C6H3Cl2NO4S
    Molecular Weight:256.06
    CAS Registry Number:97-08-5
  • Dexamethasone

    Dexamethasone

    Product Name:Dexamethasone
    Molecular Formula:C22H29FO5
    Molecular Weight:392.47
    CAS Registry Number;50-02-2
  • Related Blog
  • Reviews

  • Differences Between Pharmaceutical Raw Materials, Excipients and Pharmaceutical Intermediates

    In the pharmaceutical industry, there are various names of raw materials, such as pharmaceutical raw materials, pharmaceutical intermediates and pharmaceutical excipients in the process of pharmaceutical production. This article will take everyone to recognize these three concepts.

  • Development Trend of China's Pharmaceutical Intermediate Industry

    The rapid development of China's pharmaceutical intermediate industry is closely related to its national policies. Since 2016, China has issued clear documents to encourage small and medium-sized enterprises to develop new drugs, including chemical raw materials. At the same time, the structural upgrading of the pharmaceutical industry in developed countries has promoted the transfer of global related industrial chains and promoted China's chemical raw material drug supply chain. In addition, the increase in Chinese radiography technology has boosted product demand.

  • FDA approves lorlatinib for second- or third-line treatment of ALK-positive metastatic NSCLC

    On November 2, 2018, the Food and Drug Administration granted accelerated approval to lorlatinib (LORBRENA, Pfizer, Inc.) for patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) whose disease has progressed on crizotinib and at least one other ALK inhibitor for metastatic disease or whose disease has progressed on alectinib or ceritinib as the first ALK inhibitor therapy for metastatic disease.

  • How is a drug produced?

    ​There are so many different drugs ,with different color /shape ( like capsule ,tablet or Infusion) and price . Here we would like to explain , what makes it so different? How is a drug produced?

  • Why API manufacturing companies almostly in China?

    In the chemical API industry, developed countries such as the United States and Europe occupy a dominant position in the field of patented APIs with high added value by virtue of their advantages in research and development, production technology, and intellectual property protection...

  • What is the difference between API and FDF in pharma？

    In the pharmaceutical industry, you might hear the terms “FDF” and “API” frequently used in reference to products. We surely understand this type of jargon, but we certainly can see how the general public would feel overwhelmed looking at those kinds of terminology abbreviations. This article is for explaining the difference between API and FDF. For reference, they mean, respectively, “finished dosage form” and “active pharmaceutical ingredient.”

Related Search

CAS NO 272778-12-8

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept